Mar Bellido, MD, PhD

University Medical Center Groningen and University of Groningen, Netherlands

Poster(s):

• 1606 - Epcoritamab Monotherapy in Patients with First-Line Richter’s Transformation: 2-Year Follow-Up Results From the Phase 1b/2 EPCORE CLL-1 Clinical Trial